Updated: Aug 28, 2019
February National Provider Data Summary
The following 3 Trusts did not submit any RTT pathway data:
Gloucestershire Hospitals NHS Foundation Trust (RTE)
Mid Essex Hospital Services NHS Trust (RQ8)
Royal Free London NHS Foundation Trust (RAL)
As the below heatmap and graph shows, there has been a substantial deterioration in RTT performance nationally when compared to February 2018.
Waiting List Size
As the below graph demonstrates, from March 2018 to February 2019 the total waiting list size increased from 3,843,182 to 4,144,110, an increase of 300,928 (7.83%).
Below is a table showing each reporting Trusts variance in waiting list size from March 2018 to February 2019, sorted by percentage variance (please click to view the whole table).
52 Week Waiters
The below heatmap shows how the number of 52-week waiters has changed nationally, with some areas such as the South West suffering a significant increase, the East Midlands are suffering from a less significant increase and other areas such as the North are managing to reduce their number of 52-week waiters.
Below is a table showing each reporting Trust’s variance in 52-week waiters from March 2018 to February 2019, sorted by percentage variance (please click to view the whole table).
Changes to the Individual Specialties
In regard to the waiting list size of the individual specialties:
Plastic Surgery and Dermatology both saw a high percentage decrease in the waiting list size. Plastic Surgery seeing a percentage decrease of 4.25% and Dermatology seeing a percentage decrease of 3.17%.
Dermatology also saw a high decrease in the waiting list size going from 203,143 to 196,691, a decrease of -6,452 pathways.
Oral Surgery and Cardiothoracic Surgery saw a percentage increase of the waiting list size with Oral Surgery going from 167,306 to 169,379, a percentage increase of 1.23% and Cardiothoracic Surgery going from 8,580 to 8,698, a percentage increase of 1.37%.
Gynaecology, as a single specialty saw the largest increase of pathways, going from 259,360 to 263,720, an increase of 4,360 pathways (1.68%).
At the end of February 2019, 87.0% of patients waiting to start treatment (incomplete pathways) were waiting up to 18 weeks, thus not meeting the 92% standard, and a waiting list size of 4,144,110.
The number of RTT patients waiting to start treatment at the end of February 2019 was 4.14 million patients. Of those, 1,963 patients were waiting more than 52 weeks.
For patients waiting to start treatment at the end of February 2019, the median waiting time was 6.7 weeks. The 92nd percentile waiting time was 22.1 weeks.
During February 2019, 284,212 RTT patients started admitted treatment and 1,033,312 started non-admitted treatment (completed pathways).